EPISURF MEDICAL AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.265 SEK | -13.11% |
|
-28.18% | -73.23% |
| 24/04 | Episurf Medical Announces Distributor Agreement with Depuy-Synthes | CI |
| 24/04 | Episurf Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Presenter SpeechMartin Westerlund (Analysts)Hi, and welcome to today's webcast with Episurf. T...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Episurf Medical AB is a Sweden-based medical technology company. It is engaged in the development, manufacture and marketing of implants and surgical drilling templates used in the treatment of local cartilage damage in knee joints. The Companyâs product portfolio includes the Episealer, and individually customized implant used as a cartilage replacement for early-stage patients; and Epiguide, a drill guide designed to attach to the kneeâs surface, as well as related surgical tools. The personalization of implants and instruments is based on magnetic resonance imaging (MRI) and enables less invasive treatment. The process of ordering and creation of patient-specific implants and surgical instruments is covered by software suite, microiFidelity, comprising microiClinic, microiDesign and microiManufacture. The main shareholder of the Company is Serendipity Ixora Fund AB.
Calendar
12/07/2024
- Q2 2024 Earnings Release
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -73.23% | 76.9L | |
| +12.05% | 13TCr | |
| -8.69% | 1.09TCr | |
| -0.49% | 868.67Cr | |
| +36.99% | 548.15Cr | |
| -21.98% | 471.57Cr | |
| -10.32% | 275.57Cr | |
| -12.70% | 204.98Cr | |
| -13.26% | 192.78Cr | |
| -27.86% | 167.34Cr |
- Stock Market
- Equities
- EPIS B Stock
- News Episurf Medical AB
- Transcript : Episurf Medical AB, Q2 2021 Earnings Call, Jul 16, 2021
